Understand the source comparison
Real Peptides Orforglipron vs Competitors: Quality Benchmarks That Matter
HPLC Purity ≥98.5% (verified per batch) ≥95% (claimed, not batch-verified) ≥97% (verified quarterly) Real Peptides guarantees purity on every shipment. Competitors test sporadically or rely on supplier COAs Enantiomeric Excess (ee) >99% (chiral HPLC confirmed)
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- HPLC Purity
- ≥98.5% (verified per batch)
- ≥95% (claimed, not batch-verified)
- ≥97% (verified quarterly)
- Real Peptides guarantees purity on every shipment. Competitors test sporadically or rely on supplier COAs
- Enantiomeric Excess (ee)
- >99% (chiral HPLC confirmed)
- Not disclosed
- Not tested
- Stereoisomer contamination reduces receptor affinity by 60%+. Only Real Peptides verifies chirality
- Residual Solvent Testing
- <50 ppm DMF/acetonitrile (GC-MS)
- Solvent contamination accelerates degradation during storage. Untested batches fail after 6–12 months
- Functional Receptor Assay
- EC50 confirmation on every batch
- Not performed
- Chemical purity doesn't guarantee receptor activation. Functional testing is the only proof of efficacy
- Storage Stability Data
- 24-month stability at 20°C (light-protected)
- 12-month claim (no supporting data)
- 18-month claim (based on peptide protocols)
- Real Peptides provides actual degradation curves. Competitors extrapolate from unrelated compounds
- Professional Assessment
- Only supplier conducting receptor binding verification. Guarantees pharmacological activity, not just chemical purity
- Cheaper per gram but higher research failure risk due to unverified stereochemistry
- Peptide expertise doesn't translate to small-molecule quality control. Chiral purity overlooked
- The bottom line: orforglipron quality isn't just about purity percentage. It's about whether the synthesized molecule retains the exact three-dimensional structure required for GLP-1 receptor engagement. Real Peptides is the only supplier we're aware of that confirms functional activity on every batch through receptor binding assays, eliminating the research risk of chemically pure but pharmacologically inactive compounds.